Risk Factors for Developing Infection Among Patients with Previous Carbapenem-Resistant Acinetobacter baumannii in Respiratory Colonization in the General Wards.
{"title":"Risk Factors for Developing Infection Among Patients with Previous Carbapenem-Resistant <i>Acinetobacter baumannii</i> in Respiratory Colonization in the General Wards.","authors":"Guowen Chen, Jianjun Liao, Jinliang Mo, Baojun Guo, Haiming Niu, Miaolian Chen","doi":"10.1177/10766294251382786","DOIUrl":null,"url":null,"abstract":"<p><p><b><i>Purpose:</i></b> Carbapenem-resistant <i>Acinetobacter baumannii</i> (CRAB) is an opportunistic infectious agent that can cause bacterial colonization and nosocomial infection. This study aims to explore independent risk factors associated with progression from respiratory colonization to infection among CRAB-colonized patients in the general wards. <b><i>Methods:</i></b> We performed a retrospective study among 202 CRAB-colonized patients in the general wards of our hospital between January 2021 and December 2023. We employed both univariate and multivariable logistic regression models to explore factors associated with the progression from colonization to infection. <b><i>Results:</i></b> Among 202 CRAB-colonized patients, 66 experienced progression to subsequent infection and 36 died within 28 days. CRAB-colonized patients with subsequent infection had a significantly higher mortality rate (27.27% vs. 13.24%) than patients without infection (<i>p</i> = 0.014). After performing multivariate logistic regression analysis, CRAB-colonized patients with lower albumin (ALB) levels (OR = 0.94, <i>p</i> = 0.029), as well as those receiving antibiotics (OR = 2.49, <i>p</i> = 0.020) or glucocorticoids (OR = 2.49, <i>p</i> = 0.005), were at higher risk of subsequent infection. Furthermore, among patients with CRAB infection developed after colonization, the use of antifungal drugs (OR = 18.06, <i>p</i> = 0.002) and central venous catheter (OR = 10.73, <i>p</i> = 0.002) was the factors that associated with 28-day mortality. <b><i>Conclusion:</i></b> Our study analyzed CRAB colonization and infection in general medicine wards. Lower ALB levels and antibiotic/glucocorticoid use were risk factors for infection in colonized patients. Among those developing CR-CRAB infection, antifungal use and central venous catheters were associated with 28-day mortality. These findings can inform preventive and therapeutic guidelines for CRAB infections.</p>","PeriodicalId":18701,"journal":{"name":"Microbial drug resistance","volume":" ","pages":""},"PeriodicalIF":1.9000,"publicationDate":"2025-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Microbial drug resistance","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/10766294251382786","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: Carbapenem-resistant Acinetobacter baumannii (CRAB) is an opportunistic infectious agent that can cause bacterial colonization and nosocomial infection. This study aims to explore independent risk factors associated with progression from respiratory colonization to infection among CRAB-colonized patients in the general wards. Methods: We performed a retrospective study among 202 CRAB-colonized patients in the general wards of our hospital between January 2021 and December 2023. We employed both univariate and multivariable logistic regression models to explore factors associated with the progression from colonization to infection. Results: Among 202 CRAB-colonized patients, 66 experienced progression to subsequent infection and 36 died within 28 days. CRAB-colonized patients with subsequent infection had a significantly higher mortality rate (27.27% vs. 13.24%) than patients without infection (p = 0.014). After performing multivariate logistic regression analysis, CRAB-colonized patients with lower albumin (ALB) levels (OR = 0.94, p = 0.029), as well as those receiving antibiotics (OR = 2.49, p = 0.020) or glucocorticoids (OR = 2.49, p = 0.005), were at higher risk of subsequent infection. Furthermore, among patients with CRAB infection developed after colonization, the use of antifungal drugs (OR = 18.06, p = 0.002) and central venous catheter (OR = 10.73, p = 0.002) was the factors that associated with 28-day mortality. Conclusion: Our study analyzed CRAB colonization and infection in general medicine wards. Lower ALB levels and antibiotic/glucocorticoid use were risk factors for infection in colonized patients. Among those developing CR-CRAB infection, antifungal use and central venous catheters were associated with 28-day mortality. These findings can inform preventive and therapeutic guidelines for CRAB infections.
目的:耐碳青霉烯鲍曼不动杆菌(CRAB)是一种机会性感染因子,可引起细菌定植和医院感染。本研究旨在探讨普通病房中螃蟹定植患者从呼吸道定植到感染进展的独立危险因素。方法:对2021年1月至2023年12月在我院普通病房就诊的202例螃蟹定植患者进行回顾性研究。我们采用单变量和多变量逻辑回归模型来探索与从定植到感染进展相关的因素。结果:202例螃蟹定植患者中,66例出现后续感染进展,36例在28天内死亡。随后感染的患者死亡率(27.27% vs. 13.24%)显著高于未感染的患者(p = 0.014)。经多因素logistic回归分析,螃蟹定群中白蛋白(ALB)水平较低的患者(OR = 0.94, p = 0.029)以及接受抗生素(OR = 2.49, p = 0.020)或糖皮质激素(OR = 2.49, p = 0.005)的患者后续感染的风险较高。此外,在定植后发生螃蟹感染的患者中,使用抗真菌药物(OR = 18.06, p = 0.002)和中心静脉导管(OR = 10.73, p = 0.002)是与28天死亡率相关的因素。结论:本研究分析了普通内科病房CRAB的定植和感染情况。较低的ALB水平和抗生素/糖皮质激素的使用是定植患者感染的危险因素。在发生CR-CRAB感染的患者中,使用抗真菌药物和中心静脉导管与28天死亡率相关。这些发现可以为螃蟹感染的预防和治疗提供指导。
期刊介绍:
Microbial Drug Resistance (MDR) is an international, peer-reviewed journal that covers the global spread and threat of multi-drug resistant clones of major pathogens that are widely documented in hospitals and the scientific community. The Journal addresses the serious challenges of trying to decipher the molecular mechanisms of drug resistance. MDR provides a multidisciplinary forum for peer-reviewed original publications as well as topical reviews and special reports.
MDR coverage includes:
Molecular biology of resistance mechanisms
Virulence genes and disease
Molecular epidemiology
Drug design
Infection control.